that allows for more accurate quantification of splicing and because the distribution of well-characterized low- and high-risk CLL prognostic factors was similar between the SF3B1 mutated and wild-type samples (Fig. 4A). Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.